Member Sites

Twenty-seven leading US institutions have been selected by the NCI to be member sites of the CITN. Member Site PIs collaborate to ensure the scientific quality of CITN research, and treatment options developed through the CITN are made available to patients with cancer seen at our network institutions via clinical trials.

**Member Sites & Principal Investigators**
Institution	Principal Investigator(s)
Baylor Research Institute & Mt. Sinai School of Medicine	Karolina Palucka, MD, PhD
Case Western Reserve University	Pierre Triozzi, MD
Dana Farber Cancer Center	Steven Hodi, MD
Dartmouth-Hitchcock Norris Cotton Cancer Center	Marc Ernstoff, MD
Duke University Medical Center	Kim Lyerly, MD, FACS
Emory University	Edmund Waller, MD, PhD
Fred Hutchinson Cancer Research Center	John A. Thompson, MD
MD Anderson Cancer Center	Laurence J.N. Cooper, MD, PhD
H. Lee Moffitt Cancer Center	Scott J. Antonia, MD, PhD
Memorial Sloan-Kettering Cancer Center	Jedd D. Wolchok, MD, PhD
New York University Cancer Institute	Nina Bhardwaj, MD, PhD
Ohio State University	William E. Carson, MD
Providence Cancer Center	Walter J. Urba, MD, PhD
Roswell Park Cancer Center	Kunle Odunsi, MD, PhD
Rush University Cancer Center	Howard Kaufman, MD
Stanford University	Ronald Levy, MD
University of California, San Diego	Thomas J Kipps, MD, PhD
University of California, San Francisco	Lawrence Fong, MD
University of Chicago	Thomas Gajewski, MD, PhD
University of Miami	Joseph D. Rosenblatt, MD
University of Minnesota	Jeffrey S. Miller, MD
University of Pennsylvania	Carl June, MD
University of Pittsburgh	Robert Louis Ferris, MD, PhD Hassane M. Zarour, MD
University of Toronto Ontario Cancer Institute	Pamela Ohashi, PhD
University of Virginia	Craig Slingluff, MD
University of Wisconsin	Paul M. Sondel, MD, PhD
Yale University	Mario Sznol, MD